Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
100%(2 trials)

Phase Distribution

Ph phase_3
2
50%
Ph phase_1
2
50%

Phase Distribution

2

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 3Large-scale testing
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Not yet recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (50.0%)
Phase 32 (50.0%)

Trials by Status

completed250%
not_yet_recruiting125%
enrolling_by_invitation125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingphase_3

Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections

NCT06800248
enrolling_by_invitationphase_3

Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections

NCT06736691
completedphase_1

First in Man Clinical Trial of Emodepside (BAY 44-4400)

NCT02661178
completedphase_1

Relative Bioavailability Study of Emodepside IR-tablets and Solution

NCT03383523

Clinical Trials (4)

Showing 4 of 4 trials
NCT06800248Phase 3

Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections

Not Yet Recruiting
NCT06736691Phase 3

Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections

Enrolling By Invitation
NCT02661178Phase 1

First in Man Clinical Trial of Emodepside (BAY 44-4400)

Completed
NCT03383523Phase 1

Relative Bioavailability Study of Emodepside IR-tablets and Solution

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4